scholarly article | Q13442814 |
P50 | author | P-Y Zheng | Q84341633 |
P2093 | author name string | Gang Liu | |
Xiuli An | |||
Feifei Ren | |||
Lixiang Chen | |||
Fumin Xue | |||
Xinhua Guo | |||
Jinpeng Li | |||
Lu Mei | |||
Xiangdong Sun | |||
Chao An | |||
Haibin Sun | |||
Youcai Tang | |||
P2860 | cites work | Protein 4.1B expression is induced in mammary epithelial cells during pregnancy and regulates their proliferation. | Q52044845 |
EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma. | Q52724780 | ||
Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation | Q68818445 | ||
Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma | Q81190898 | ||
Gastric cancer | Q89391950 | ||
Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition | Q90982572 | ||
Conformational coupling across the plasma membrane in activation of the EGF receptor | Q24313122 | ||
Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin | Q24672506 | ||
The tumor suppressor DAL-1/4.1B and protein methylation cooperate in inducing apoptosis in MCF-7 breast cancer cells | Q25257451 | ||
Filopodia and adhesion in cancer cell motility | Q26823315 | ||
Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach | Q26828506 | ||
Protein 4.1R core domain structure and insights into regulation of cytoskeletal organization | Q27627296 | ||
Structural Basis of Tumor Suppressor in Lung Cancer 1 (TSLC1) Binding to Differentially Expressed in Adenocarcinoma of the Lung (DAL-1/4.1B) | Q27666177 | ||
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
Protein tyrosine kinase structure and function | Q28145008 | ||
The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane | Q28284187 | ||
Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human | Q28289844 | ||
Structure of the spectrin-actin binding site of erythrocyte protein 4.1 | Q28300044 | ||
Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates | Q28624927 | ||
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells | Q29616544 | ||
A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function | Q33240466 | ||
Gene expression patterns in human liver cancers | Q33898932 | ||
Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers. | Q34009859 | ||
Properties of the C-terminal domain of 4.1 proteins | Q34082611 | ||
Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer | Q34124246 | ||
Functional characterization of spectrin-actin-binding domains in 4.1 family of proteins | Q34131358 | ||
miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. | Q34188647 | ||
Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex | Q34287597 | ||
Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line | Q34538847 | ||
Aberrant expression of the candidate tumor suppressor gene DAL-1 due to hypermethylation in gastric cancer | Q36628545 | ||
Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines | Q37578238 | ||
A 130-kDa protein 4.1B regulates cell adhesion, spreading, and migration of mouse embryo fibroblasts by influencing actin cytoskeleton organization | Q37608511 | ||
Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer. | Q39551556 | ||
Tumor suppressor CADM1 is involved in epithelial cell structure. | Q39783893 | ||
Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer | Q40433701 | ||
Membrane localization of the U2 domain of Protein 4.1B is necessary and sufficient for meningioma growth suppression. | Q40462570 | ||
Structural diversity of band 4.1 superfamily members. | Q41458167 | ||
A Golgi-associated protein 4.1B variant is required for assimilation of proteins in the membrane | Q41897832 | ||
Immunolocalization of protein 4.1B/DAL-1 during neoplastic transformation of mouse and human intestinal epithelium | Q42166023 | ||
A basic peptide within the juxtamembrane region is required for EGF receptor dimerization | Q45149243 | ||
Protein 4.1B/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent c-Jun-NH(2)-kinase signaling. | Q48535606 | ||
P433 | issue | 1 | |
P304 | page(s) | 115 | |
P577 | publication date | 2019-09-06 | |
P1433 | published in | Cell Communication and Signaling | Q1254390 |
P1476 | title | 4.1B suppresses cancer cell proliferation by binding to EGFR P13 region of intracellular juxtamembrane segment | |
P478 | volume | 17 |
Search more.